We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
4d Pharma Plc | LSE:DDDD | London | Ordinary Share | GB00BJL5BR07 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 16.36 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
28/1/2021 08:27 | Big sell offs in the markets, what was the trigger? | katsy | |
28/1/2021 08:24 | Back to £1.25+ in following days IMO Buy fear. | under the radars | |
28/1/2021 08:22 | Back below 100p in coming days IMO | daar | |
28/1/2021 08:12 | So we are looking at £10 by Q1 according to the guru here??Guys don't sell now you have 1000% upside in 60 days.Apparently its a no brainer.You have to laugh at the mentality of some. | bluebear1 | |
27/1/2021 22:59 | Thanks Bermudashorts, I had not seen this article before. Microbiome seriously on the map and interest growing all the time is my impression | thresholdbypass | |
27/1/2021 22:09 | I have no idea whether this has already been posted but the article below explains in layman's terms some amazing research from Brigham and Women’s Hospital (Harvard). They've discovered that a certain type of brain cell can protect the brain from inflammation and that the anti-inflammatory activity of these cells is controlled by the microbiome. '“Finding microbiome-controlle | bermudashorts | |
27/1/2021 21:20 | surely that is transparent ? | swallowsflysouth | |
27/1/2021 21:15 | I think it would have been more honest if the article had read 'its more effective to get the virus and hopefully recover'. | goodgrief | |
27/1/2021 21:08 | Goodgrief, tell me something that guarantees 'complete' recovery or any other kind of recover. | swallowsflysouth | |
27/1/2021 21:04 | ... recovery isn't guaranteed. | goodgrief | |
27/1/2021 20:06 | Been here for over a year | the stigologist | |
27/1/2021 18:47 | I thought exactly the same but I think it references the immediate cash that comes with the takeover. However, I wouldn't be shocked to see a raft of news shortly after the Nasdaq listing and a raise soon after, hopefully to coincide with a decent rise in the share price to minimise dilution. The fund raise would be solely on the Nasdaq to provide liquidity which will also be needed to sustain a decent rise. That is just my humble opinion and how I see things spanning out, I am sure others have different views and I respect them. Nai, Dyor, wtfdik. | devonlad | |
27/1/2021 18:45 | Kiddies getting impatient :) | wigwammer | |
27/1/2021 18:17 | Post 033 What does anyone think is implied by the use of the word, 'immediate'? "while providing immediate access to additional funds to support our pipeline" | ptolemy | |
27/1/2021 16:15 | Not expecting any news from conference.Actually don't want it. Would have to update SEC filing holding up Nasdaq listing. | vanduke | |
27/1/2021 16:14 | Oh so eloquent Stig, if only the politicians could express themselves in such a way | churchwins | |
27/1/2021 15:52 | 22-10-20 rns Despite the tremendous operational and economic challenges in 2020 created by the global pandemic, 4D has made significant strides on a number of fronts. This includes 4D presenting clinical data for Live Biotherapeutics for the treatment of cancer in combination with MSD's Keytruda®, as well as positive Phase II results for the first drug candidate able to treat both IBS-C and IBS-D. In addition, earlier in 2020 4D was able to quickly instigate a Phase II clinical trial in COVID-19 based on our detailed understanding of our asthma program," commented Duncan Peyton, Chief Executive Officer of 4D. "We expect that a NASDAQ Listing will allow 4D to capitalise on increased interest from US healthcare investors in recent years and provide access to a much larger pool of specialist capital, thereby increasing our global profile and exposure. NASDAQ is an attractive market for growing, innovative biotech companies. The Merger will accelerate and de-risk 4D's admission to NASDAQ, while providing immediate access to additional funds to support our pipeline." | under the radars | |
27/1/2021 15:18 | All markets down today anyway by the way | thresholdbypass | |
27/1/2021 15:17 | Or buy more if you can... | thresholdbypass |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions